Evidence map›Paper›PMID 36769234›Full record

ReviewInternational journal of molecular sciences2023

Endothelial Dysfunction in Neurodegenerative Diseases.

Yao-Ching Fang, Yi-Chen Hsieh, Chaur-Jong Hu, Yong-Kwang Tu

Registry-linked trialAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07221266 (Changes in Motor Function, Quality of Life, Cardiorespiratory Fitness, and Physiological Markers in People With Parkinson's Disease Following Different Exercise Interventions.), which is not on this map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07221266 narecruitingnot on this mapstarted 2026, after this paper: background citation

Changes in Motor Function, Quality of Life, Cardiorespiratory Fitness, and Physiological Markers in People With Parkinson's Disease Following Different Exercise Interventions.

TypeinterventionalSponsorUniversity of Texas, El PasoRan2026 to 2027Enrolled45ConditionsParkinson Disease (PD)ArmsGuided Cycling, Non-Contact Boxing, Traditional Physical Therapy Program (Standard of Care)
3 · Its place in the literature

Who cites it

52 citing papers in PubMed.

  1. A modifiable driver of dementia: cognitive impairment in primary aldosteronism.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yao-Ching FangTaipei Neuroscience Institute, Taipei Medical University, Taipei 11031, Taiwan.
Yi-Chen HsiehGraduate Institute of Neural Regenerative Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.ORCID 0000-0002-1863-287X
Chaur-Jong HuTaipei Neuroscience Institute, Taipei Medical University, Taipei 11031, Taiwan.ORCID 0000-0002-4900-5967
Yong-Kwang TuTaipei Neuroscience Institute, Taipei Medical University, Taipei 11031, Taiwan.

Funding

Taipei Medical University-Shuang Ho Hospital 107TMU-SHH-16, 108TMU-SHH-12
6 · The paper itself

Abstract

The cerebral vascular system stringently regulates cerebral blood flow (CBF). The components of the blood-brain barrier (BBB) protect the brain from pathogenic infections and harmful substances, efflux waste, and exchange substances; however, diseases develop in cases of blood vessel injuries and BBB dysregulation. Vascular pathology is concurrent with the mechanisms underlying aging, Alzheimer's disease (AD), and vascular dementia (VaD), which suggests its involvement in these mechanisms. Therefore, in the present study, we reviewed the role of vascular dysfunction in aging and neurodegenerative diseases, particularly AD and VaD. During the development of the aforementioned diseases, changes occur in the cerebral blood vessel morphology and local cells, which, in turn, alter CBF, fluid dynamics, and vascular integrity. Chronic vascular inflammation and blood vessel dysregulation further exacerbate vascular dysfunction. Multitudinous pathogenic processes affect the cerebrovascular system, whose dysfunction causes cognitive impairment. Knowledge regarding the pathophysiology of vascular dysfunction in neurodegenerative diseases and the underlying molecular mechanisms may lead to the discovery of clinically relevant vascular biomarkers, which may facilitate vascular imaging for disease prevention and treatment.

Indexed as

Alzheimer DiseaseCognitive DysfunctionDementia, VascularNeurodegenerative DiseasesVascular DiseasesBlood-Brain BarrierBrainHumansAlzheimer’s disease (AD)blood–brain barrier (BBB)cerebral blood flow (CBF)vascular dementia (VaD)

Identifiers

PMID36769234
PMCPMC9918222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.